Clinical Trial: An Observational Study to Assess Optive MEGA-3 (OM3) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Dry Eye
Study Type: OBSERVATIONAL
Official Title: Patient Experience Study Evaluating Effect of OM3 on Dry Eye Symptoms and Quality of Life in Patients With Mild to Moderate Dry Eye Disease
Brief Summary:
Dry Eye Disease (DED) is a condition where the tear film of the eye becomes unstable and along with ocular surface inflammation and damage leads to inadequate tear production and eye lubrication.This study will evaluate real-world experiences with Optive MEGA-3 (OM3) on relieving dry eye symptoms in adult participants with DED.OM3 is an over the counter (OTC) monograph drug indicated for the temporary relief of symptoms of eye dryness.Participants will administer 1 drop of OM3 on Day 1 for the acute phase of the…
Read more